Successful use of aflibercept for high cardiac output in hereditary hemorrhagic telangiectasia after failure of pazopanib and bevacizumab therapy, Journal of Thrombosis and Haemostasis, (2025 ...

Hereditary hemorrhagic telangiectasia (HTT) has similar symptoms, but veins in the lungs, liver, and gut are also affected. This condition requires close monitoring and treatment.

HealthDay News — For patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide yields a significant reduction in epistaxis severity, according to a study published in the September ...

Benign hereditary telangiectasia is an inherited condition that causes dilated blood vessels on your skin and lips. Unlike other similar conditions, it does not cause any systemic symptoms. Benign ...

‘#Hereditary_hemorrhagic_telangiectasia (HHT) is a rare #bleeding disorder that affects more than 1 in 5,000 individuals globally. #medindia ’ A single patient sparked this trial.

Osler-Weber-Rendu syndrome, which is also called hereditary hemorrhagic telangiectasia (HHT), is a rare genetic disorder that causes atypical blood vessels to form in your skin and mucous ...

WATERTOWN, Mass. , March 04, 2025 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company focused on correcting dysregulated signaling with multispecific antibodies that address the ...

Telangiectasia refers to small, dilated blood vessels visible near the skin or mucous membranes' surface, often appearing on the face, legs, chest, or other areas. These vessels may be red, blue ...

Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia. New England Journal of Medicine , 2024; 391 (11): 1015 DOI: 10.1056/NEJMoa2312749 Cite This Page : ...

Heather Balch, MD, is a physician at the University of Utah Hospital. As an internal medicine hospitalist, her interests include caring for acutely ill hospitalized adult patients with complex ...

Study conducted in partnership with Cure HHT will inform future clinical trials and treatment options for people living with HHT Company recently progressed DIAG723 into IND-enabling studies for ...